Humanin: dosing in studies (preclinical)
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
Humanin is described in sources as a subcutaneous (SC) injection; the HNG (S14G) analog is markedly more potent and so is used in smaller amounts. The figures are a generalized reference from preclinical work and community protocols, with no approved clinical dosing.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Native humanin (SC) | 1–3 mg, 2–3x per week | Starting dose |
| HNG / S14G analog (SC) | 100–500 mcg, 2–3x per week | More potent form, lower dose |
| Cycle length | 4–8 weeks, then off | Maximum in this schedule |